Foyston, Gordon, & Payne’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-41,112
Closed -$1.46M 74
2015
Q1
$1.46M Sell
41,112
-184,022
-82% -$6.2M 0.22% 54
2014
Q4
$7.8M Sell
225,134
-124,806
-36% -$4.4M 1.11% 37
2014
Q3
$12.4M Sell
349,940
-15,710
-4% -$593K 1.78% 20
2014
Q2
$14.7M Sell
365,650
-38,390
-10% -$1.47M 1.87% 21
2014
Q1
$16.1M Sell
404,040
-18,228
-4% -$656K 1.99% 21
2013
Q4
$13.9M Sell
422,268
-17,670
-4% -$551K 1.73% 22
2013
Q3
$12.9M Buy
439,938
+269,818
+159% +$8.46M 1.69% 23
2013
Q2
$5.73M Buy
+170,120
New +$5.26M 0.85% 43

Other funds holding DBD

Foyston, Gordon, & Payne's DBD Position: Q2 2015 in Review

Foyston, Gordon, & Payne sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2015, closing a stake of 41,112 shares — an estimated $1.46M sold.

Foyston, Gordon, & Payne first reported a position in DBD in Q2 2013 and held it in 8 quarters. The position peaked at $16.1M in Q1 2014. 228 funds tracked by Wall St. Rank hold DBD as of Q2 2015.

  • Foyston, Gordon, & Payne reported no remaining Diebold Nixdorf Incorporated position as of Q2 2015 after selling out during the quarter.
  • Foyston, Gordon, & Payne sold 41,112 Diebold Nixdorf Incorporated shares in Q2 2015, an estimated $1.46M.
  • Foyston, Gordon, & Payne first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 8 quarters.
  • Foyston, Gordon, & Payne's Diebold Nixdorf Incorporated position peaked at $16.1M in Q1 2014.
  • 228 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2015.

Based on Foyston, Gordon, & Payne's 13F filing for Q2 2015, filed 14 Aug 2015.